Determination of Breast Cancer Prognosis After Neoadjuvant Chemotherapy Using Residual Cancer Burden and Neo-Bioscore
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Determination of Breast Cancer Prognosis After Neoadjuvant Chemotherapy: Comparison of Residual Cancer Burden (RCB) and Neo-Bioscore
Br. J. Cancer 2021 Feb 09;[EPub Ahead of Print], E Laas, J Labrosse, AS Hamy, G Benchimol, D de Croze, JG Feron, F Coussy, T Balezeau, J Guerin, M Lae, JY Pierga, F ReyalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.